avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxp1 | mm10_v2_chr6_-_99028251_99028313 | -0.57 | 2.6e-04 | Click! |
Foxj2 | mm10_v2_chr6_+_122819888_122819938 | -0.51 | 1.3e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_81975742 Show fit | 28.77 |
ENSMUST00000029645.8
|
tryptophan 2,3-dioxygenase |
|
chr6_+_122006798 Show fit | 24.05 |
ENSMUST00000081777.6
|
murinoglobulin 2 |
|
chr1_-_139781236 Show fit | 22.29 |
ENSMUST00000027612.8
ENSMUST00000111989.2 ENSMUST00000111986.2 |
predicted gene 4788 |
|
chr1_-_130661584 Show fit | 19.87 |
ENSMUST00000137276.2
|
complement component 4 binding protein |
|
chr1_-_130661613 Show fit | 19.51 |
ENSMUST00000027657.7
|
complement component 4 binding protein |
|
chr2_+_68117713 Show fit | 19.26 |
ENSMUST00000112346.2
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
|
chr5_-_145879857 Show fit | 19.25 |
ENSMUST00000035918.7
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
|
chr12_-_104153846 Show fit | 18.77 |
ENSMUST00000085050.3
|
serine (or cysteine) peptidase inhibitor, clade A, member 3C |
|
chr19_-_39463067 Show fit | 17.20 |
ENSMUST00000035488.2
|
cytochrome P450, family 2, subfamily c, polypeptide 38 |
|
chr10_+_127898515 Show fit | 16.76 |
ENSMUST00000047134.7
|
4short chain dehydrogenase/reductase family 9C, member 7 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 88.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 41.2 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
12.7 | 38.2 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
5.1 | 30.4 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
1.5 | 25.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
4.9 | 24.7 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.5 | 22.6 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
5.6 | 22.3 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.7 | 22.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.7 | 19.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 103.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 95.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 79.0 | GO:0005740 | mitochondrial envelope(GO:0005740) |
1.1 | 44.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
3.4 | 30.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 27.9 | GO:0000139 | Golgi membrane(GO:0000139) |
2.4 | 24.1 | GO:0005579 | membrane attack complex(GO:0005579) |
2.7 | 21.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 19.4 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 19.2 | GO:0005581 | collagen trimer(GO:0005581) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 76.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.9 | 33.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.9 | 31.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
7.2 | 28.8 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.9 | 24.9 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
4.1 | 24.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 23.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
4.3 | 21.7 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
7.1 | 21.3 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
6.7 | 20.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 30.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 28.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.6 | 28.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 24.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 18.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 16.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 15.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 15.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 12.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 11.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 50.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.5 | 46.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
2.1 | 38.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
2.4 | 34.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.1 | 24.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.3 | 21.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
2.5 | 19.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 17.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 16.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
2.7 | 16.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |